Secretion of the fungal toxin candidalysin is dependent on conserved precursor peptide sequences.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 22 11 2022
accepted: 12 01 2024
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

The opportunistic fungal pathogen Candida albicans damages host cells via its peptide toxin, candidalysin. Before secretion, candidalysin is embedded in a precursor protein, Ece1, which consists of a signal peptide, the precursor of candidalysin and seven non-candidalysin Ece1 peptides (NCEPs), and is found to be conserved in clinical isolates. Here we show that the Ece1 polyprotein does not resemble the usual precursor structure of peptide toxins. C. albicans cells are not susceptible to their own toxin, and single NCEPs adjacent to candidalysin are sufficient to prevent host cell toxicity. Using a series of Ece1 mutants, mass spectrometry and anti-candidalysin nanobodies, we show that NCEPs play a role in intracellular Ece1 folding and candidalysin secretion. Removal of single NCEPs or modifications of peptide sequences cause an unfolded protein response (UPR), which in turn inhibits hypha formation and pathogenicity in vitro. Our data indicate that the Ece1 precursor is not required to block premature pore-forming toxicity, but rather to prevent intracellular auto-aggregation of candidalysin sequences.

Identifiants

pubmed: 38388771
doi: 10.1038/s41564-024-01606-z
pii: 10.1038/s41564-024-01606-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Hu 528/20-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Priority Program 2225 Exit Strategies of extracellular pathogens
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 390713860
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 210879364
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 390713860
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Hu 528/20-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Priority Program 2225 Exit Strategies of extracellular pathogens
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Priority Program 2225 Exit Strategies of extracellular pathogens
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Hu- 528/20-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 210879364 Z2
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 210879364 Z2
Organisme : Wellcome Trust (Wellcome)
ID : 215599_Z_19_Z
Organisme : Wellcome Trust (Wellcome)
ID : 215599_Z_19_Z
Organisme : Wellcome Trust (Wellcome)
ID : 214229/Z/18/Z
Organisme : Leibniz-Gemeinschaft (Leibniz Association)
ID : SAS-2015-HKI-LWC
Organisme : Leibniz-Gemeinschaft (Leibniz Association)
ID : SAS-2015-HKI-LWC
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 13N15705
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : FKZ 01K12012
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : LPI-BT2, 13N15705
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : R01AI073289
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : R01AI073289
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : CRSII5_173863 /1
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : CRSII5_173863 /1
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : CRSII5_173863 /1

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Bischofberger, M., Iacovache, I. & van der Goot, F. G. Pathogenic pore-forming proteins: function and host response. Cell Host Microbe 12, 266–275 (2012).
pubmed: 22980324 doi: 10.1016/j.chom.2012.08.005
Krawczyk, P. A., Laub, M. & Kozik, P. To kill but not be killed: controlling the activity of mammalian pore-forming proteins. Frontiers in Immunology 11, 601405 (2020).
Henry, B. D. et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33, 81–88 (2015).
pubmed: 25362245 doi: 10.1038/nbt.3037
Yakimova, E. T., Yordanova, Z. P., Slavov, S., Kapchina-Toteva, V. M. & Woltering, E. J. Alternaria alternata AT toxin induces programmed cell death in tobacco. J. Phytopathol. 157, 592–601 (2009).
doi: 10.1111/j.1439-0434.2008.01535.x
Curtis, M. J. & Wolpert, T. J. The victorin-induced mitochondrial permeability transition precedes cell shrinkage and biochemical markers of cell death, and shrinkage occurs without loss of membrane integrity. Plant J. 38, 244–259 (2004).
pubmed: 15078328 doi: 10.1111/j.1365-313X.2004.02040.x
Fernández-García, L. et al. Toxin-antitoxin systems in clinical pathogens. Toxins 8, 227 (2016).
pubmed: 27447671 pmcid: 4963858 doi: 10.3390/toxins8070227
Wang, X., Yao, J., Sun, Y.-C. & Wood, T. K. Type VII toxin/antitoxin classification system for antitoxins that enzymatically neutralize toxins. Trends Microbiol. 29, 388–393 (2021).
pubmed: 33342606 doi: 10.1016/j.tim.2020.12.001
Peraro, M. D. & van der Goot, F. G. Pore-forming toxins: ancient, but never really out of fashion. Nat. Rev. Microbiol. 14, 77–92 (2016).
doi: 10.1038/nrmicro.2015.3
Gonzalez, M. R., Bischofberger, M., Pernot, L., van der Goot, F. G. & Freche, B. Bacterial pore-forming toxins: the (w)hole story? Cell. Mol. Life Sci. 65, 493–507 (2008).
pubmed: 17989920 doi: 10.1007/s00018-007-7434-y
Los, F. C., Randis, T. M., Aroian, R. V. & Ratner, A. J. Role of pore-forming toxins in bacterial infectious diseases. Microbiol. Mol. Biol. Rev. 77, 173–207 (2013).
pubmed: 23699254 pmcid: 3668673 doi: 10.1128/MMBR.00052-12
Peschel, A. & Otto, M. Phenol-soluble modulins and staphylococcal infection. Nat. Rev. Microbiol. 11, 667–673 (2013).
pubmed: 24018382 pmcid: 4780437 doi: 10.1038/nrmicro3110
Cheung, G. Y., Joo, H. S., Chatterjee, S. S. & Otto, M. Phenol-soluble modulins–critical determinants of staphylococcal virulence. FEMS Microbiol. Rev. 38, 698–719 (2014).
pubmed: 24372362 doi: 10.1111/1574-6976.12057
Moyes, D. L. et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532, 64–68 (2016).
pubmed: 27027296 pmcid: 4851236 doi: 10.1038/nature17625
Mayer, F. L., Wilson, D. & Hube, B. Candida albicans pathogenicity mechanisms. Virulence 4, 119–128 (2013).
pubmed: 23302789 pmcid: 3654610 doi: 10.4161/viru.22913
Richardson, J. P. et al. Processing of Candida albicans Ece1p is critical for candidalysin maturation and fungal virulence. mBio 9, e02178-17 (2018).
pubmed: 29362237 pmcid: 5784256 doi: 10.1128/mBio.02178-17
Mogavero, S. et al. Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans. Cell. Microbiol. 23, e13378 (2021).
pubmed: 34245079 pmcid: 8460606
Westman, J. et al. Calcium-dependent ESCRT recruitment and lysosome exocytosis maintain epithelial integrity during Candida albicans invasion. Cell Rep. 38, 110187 (2022).
pubmed: 34986345 pmcid: 8755444 doi: 10.1016/j.celrep.2021.110187
Ho, J. et al. Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor. Nat. Commun. 10, 2297 (2019).
pubmed: 31127085 pmcid: 6534540 doi: 10.1038/s41467-019-09915-2
Verma, A. H. et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Sci. Immunol. 2, eaam8834 (2017).
Drummond, R. A. et al. CARD9(+) microglia promote antifungal immunity via IL-1beta- and CXCL1-mediated neutrophil recruitment. Nat. Immunol. 20, 559–570 (2019).
pubmed: 30996332 pmcid: 6494474 doi: 10.1038/s41590-019-0377-2
Swidergall, M. et al. Candidalysin is required for neutrophil recruitment and virulence during systemic Candida albicans infection. J. Infect. Dis. 220, 1477–1488 (2019).
pubmed: 31401652 pmcid: 6761979 doi: 10.1093/infdis/jiz322
Chu, H. et al. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J. Hepatol. 72, 391–400 (2020).
pubmed: 31606552 doi: 10.1016/j.jhep.2019.09.029
Pekmezovic, M. et al. Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells. Nat. Microbiol. 6, 643–657 (2021).
pubmed: 33753919 doi: 10.1038/s41564-021-00875-2
Wu, Y. et al. Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization. Immunity 54, 2595–2610.e7 (2021).
pubmed: 34506733 pmcid: 8585696 doi: 10.1016/j.immuni.2021.08.009
Li, X. V. et al. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature 603, 672–678 (2022).
pubmed: 35296857 pmcid: 9166917 doi: 10.1038/s41586-022-04502-w
Liao, C. et al. Bacillus thuringiensis Cry1Ac protoxin and activated toxin exert differential toxicity due to a synergistic interplay of cadherin with ABCC transporters in the cotton bollworm. Appl. Environ. Microbiol. 88, e0250521 (2022).
pubmed: 35262369 doi: 10.1128/aem.02505-21
Schmitt, M. J. & Breinig, F. Yeast viral killer toxins: lethality and self-protection. Nat. Rev. Microbiol. 4, 212–221 (2006).
pubmed: 16489348 doi: 10.1038/nrmicro1347
Howard, S. P. & Buckley, J. T. Activation of the hole-forming toxin aerolysin by extracellular processing. J. Bacteriol. 163, 336–340 (1985).
pubmed: 3891735 pmcid: 219118 doi: 10.1128/jb.163.1.336-340.1985
Coburn, P. S. & Gilmore, M. S. The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell. Microbiol. 5, 661–669 (2003).
pubmed: 12969372 doi: 10.1046/j.1462-5822.2003.00310.x
Memariani, H. & Memariani, M. Anti-fungal properties and mechanisms of melittin. Appl. Microbiol. Biotechnol. 104, 6513–6526 (2020).
pubmed: 32500268 doi: 10.1007/s00253-020-10701-0
Keller, M. D. et al. Decoy exosomes provide protection against bacterial toxins. Nature 579, 260–264 (2020).
pubmed: 32132711 pmcid: 7519780 doi: 10.1038/s41586-020-2066-6
Almagro Armenteros, J. J. et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 37, 420–423 (2019).
pubmed: 30778233 doi: 10.1038/s41587-019-0036-z
Sircaik, S. et al. The protein kinase Ire1 impacts pathogenicity of Candida albicans by regulating homeostatic adaptation to endoplasmic reticulum stress. Cell. Microbiol. 23, e13307 (2021).
pubmed: 33403715 pmcid: 8044019 doi: 10.1111/cmi.13307
Guillemette, T. et al. Methods for investigating the UPR in filamentous fungi. Methods Enzymol. 490, 1–29 (2011).
pubmed: 21266241 doi: 10.1016/B978-0-12-385114-7.00001-5
Wimalasena, T. T. et al. Impact of the unfolded protein response upon genome-wide expression patterns, and the role of Hac1 in the polarized growth, of Candida albicans. Fungal Genet. Biol. 45, 1235–1247 (2008).
pubmed: 18602013 doi: 10.1016/j.fgb.2008.06.001
Chaffin, W. L. Effect of tunicamycin on germ tube and yeast bud formation in Candida albicans. J. Gen. Microbiol. 131, 1853–1861 (1985).
pubmed: 3903038
Sidrauski, C. & Walter, P. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell 90, 1031–1039 (1997).
pubmed: 9323131 doi: 10.1016/S0092-8674(00)80369-4
Travers, K. J. et al. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101, 249–258 (2000).
pubmed: 10847680 doi: 10.1016/S0092-8674(00)80835-1
Pincus, D. et al. BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response. PLoS Biol. 8, e1000415 (2010).
pubmed: 20625545 pmcid: 2897766 doi: 10.1371/journal.pbio.1000415
Jenssen, H., Hamill, P. & Hancock, R. E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491–511 (2006).
pubmed: 16847082 pmcid: 1539102 doi: 10.1128/CMR.00056-05
Outram, M. A., Solomon, P. S. & Williams, S. J. Pro-domain processing of fungal effector proteins from plant pathogens. PLoS Pathog. 17, e1010000 (2021).
pubmed: 34669754 pmcid: 8528282 doi: 10.1371/journal.ppat.1010000
Ceremuga, M. et al. Melittin—a natural peptide from bee venom which induces apoptosis in human leukaemia cells. Biomolecules 10, 247 (2020).
pubmed: 32041197 pmcid: 7072249 doi: 10.3390/biom10020247
Senior, A. W. et al. Improved protein structure prediction using potentials from deep learning. Nature 577, 706–710 (2020).
pubmed: 31942072 doi: 10.1038/s41586-019-1923-7
Bader, O., Krauke, Y. & Hube, B. Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris. BMC Microbiol. 8, 116 (2008).
pubmed: 18625069 pmcid: 2515848 doi: 10.1186/1471-2180-8-116
Liu, J. et al. A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis. PLoS Pathog. 17, e1009884 (2021).
pubmed: 34506615 pmcid: 8432879 doi: 10.1371/journal.ppat.1009884
Ropars, J. et al. Gene flow contributes to diversification of the major fungal pathogen Candida albicans. Nat. Commun. 9, 2253 (2018).
pubmed: 29884848 pmcid: 5993739 doi: 10.1038/s41467-018-04787-4
Stephens, M., Smith, N. J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978–989 (2001).
pubmed: 11254454 pmcid: 1275651 doi: 10.1086/319501
Stephens, M. & Scheet, P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76, 449–462 (2005).
pubmed: 15700229 pmcid: 1196397 doi: 10.1086/428594
Rupniak, H. T. et al. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J. Natl Cancer Inst. 75, 621–635 (1985).
pubmed: 2413234
Toth, R. et al. Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response. Front. Microbiol. 6, 1102 (2015).
pubmed: 26528256 pmcid: 4602145 doi: 10.3389/fmicb.2015.01102
Lockhart, S. R. et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 64, 134–140 (2017).
pubmed: 27988485 doi: 10.1093/cid/ciw691
Zarnowski, R., Sanchez, H. & Andes, D. R. Large-scale production and isolation of Candida biofilm extracellular matrix. Nat. Protoc. 11, 2320–2327 (2016).
pubmed: 27809313 doi: 10.1038/nprot.2016.132
Zarnowski, R. et al. Coordination of fungal biofilm development by extracellular vesicle cargo. Nat. Commun. 12, 6235 (2021).
pubmed: 34716343 pmcid: 8556236 doi: 10.1038/s41467-021-26525-z
Zarnowski, R. et al. A common vesicle proteome drives fungal biofilm development. Proc. Natl Acad. Sci. USA 119, e2211424119 (2022).
pubmed: 36095193 pmcid: 9501958 doi: 10.1073/pnas.2211424119
Richardson, J. P. et al. Candidalysins are a new family of cytolytic fungal peptide toxins. mBio 13, e0351021 (2022).
pubmed: 35073742 doi: 10.1128/mbio.03510-21
Li, C. et al. FastCloning: a highly simplified, purification-free, sequence- and ligation-independent PCR cloning method. BMC Biotechnol. 11, 92 (2011).
pubmed: 21992524 pmcid: 3207894 doi: 10.1186/1472-6750-11-92
Walther, A. & Wendland, J. An improved transformation protocol for the human fungal pathogen Candida albicans. Curr. Genet. 42, 339–343 (2003).
pubmed: 12612807 doi: 10.1007/s00294-002-0349-0
Wächtler, B., Wilson, D., Haedicke, K., Dalle, F. & Hube, B. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS ONE 6, e17046 (2011).
pubmed: 21407800 pmcid: 3044159 doi: 10.1371/journal.pone.0017046
von der Haar, T. Optimized protein extraction for quantitative proteomics of yeasts. PLoS ONE 2, e1078 (2007).
pubmed: 17957260 pmcid: 2031916 doi: 10.1371/journal.pone.0001078
Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2021).
pmcid: 8728224 doi: 10.1093/nar/gkab1061
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2

Auteurs

Rita Müller (R)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Annika König (A)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.
Institute of Microbiology, Friedrich Schiller University, Jena, Germany.

Sabrina Groth (S)

Division of Biophysics, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.

Robert Zarnowski (R)

Department of Medicine, Section of Infectious Diseases, University of Wisconsin-Madison, Madison, WI, USA.

Corissa Visser (C)

Institute of Microbiology, Friedrich Schiller University, Jena, Germany.
Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Tom Handrianz (T)

Division of Biophysics, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.

Corinne Maufrais (C)

Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.
Institut Pasteur, Université Paris Cité, Unité Biologie et Pathogénicité Fongiques, Paris, France.

Thomas Krüger (T)

Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Maximilian Himmel (M)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Sejeong Lee (S)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Emily L Priest (EL)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Deniz Yildirim (D)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Jonathan P Richardson (JP)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Matthew G Blango (MG)

RNA Biology of Fungal Infections, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Marie-Elisabeth Bougnoux (ME)

Institut Pasteur, Université Paris Cité, Unité Biologie et Pathogénicité Fongiques, Paris, France.
Unité de Parasitologie-Mycologie, Service de Microbiologie Clinique, Hôpital Necker-Enfants-Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Olaf Kniemeyer (O)

Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Christophe d'Enfert (C)

Institut Pasteur, Université Paris Cité, Unité Biologie et Pathogénicité Fongiques, Paris, France.

Axel A Brakhage (AA)

Institute of Microbiology, Friedrich Schiller University, Jena, Germany.
Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.
Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany.

David R Andes (DR)

Department of Medicine, Section of Infectious Diseases, University of Wisconsin-Madison, Madison, WI, USA.

Verena Trümper (V)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Christian Nehls (C)

Division of Biophysics, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Kiel Nano, Surface and Interface Science KiNSIS, Kiel University, Kiel, Germany.

Lydia Kasper (L)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Selene Mogavero (S)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany.

Thomas Gutsmann (T)

Division of Biophysics, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Kiel Nano, Surface and Interface Science KiNSIS, Kiel University, Kiel, Germany.

Julian R Naglik (JR)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Stefanie Allert (S)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany. stefanie.allert@leibniz-hki.de.

Bernhard Hube (B)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Jena, Germany. bernhard.hube@leibniz-hki.de.
Institute of Microbiology, Friedrich Schiller University, Jena, Germany. bernhard.hube@leibniz-hki.de.
Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany. bernhard.hube@leibniz-hki.de.

Classifications MeSH